Introduction It is well known that patients affected with antiphospholipid syndrome (APS) are
subject to episodes of thrombosis in arteries and/or veins, pregnancy loss (probably …

The first aCL test was developed in 1983 and subsequently standardized. Although in the
last 6 to 7 years new and more specific tests have become available, the aCL ELISA and the …

Anticardiolipin antibody (aCL) tests are important to aid the physician in diagnosis of
“Antiphospholipid Syndrome”(APS)[1]. Patients affected with APS are subject to episodes of …

Fifteen years have passed since Hughes reported the detailed clinical description of
antiphospholipid syndrome (APS), and it is now recognised as one of the most common …

It has been 20 years since The Lancet published the first report on the anticardiolipin (aCL)
test1 that identified a group of patients subject to recurrent arterial and/or venous …

Literally speaking, an antiphospholipid antibody (aPL)-negative antiphospholipid syndrome
(APS) is an oxymoron, given that aPL positivity is considered to be a sine qua non of APS …

Antiphospholipid syndrome (APS) is defined as an autoimmune disease characterised by
the presence of antiphospholipid antibodies (AAF) and at least one thrombotic clinical …

Anticardiolipin (aCL) tests are important to aid in the diagnosis of antiphospholipid
syndrome (APS). 1 Patients affected with APS are subject to episodes of thrombosis in …

The antiphospholipid syndrome (APS) is an autoimmune disease that is characterized by
the presence of antiphospholipid antibodies in plasma of patients suffering from venous or …

The anticardiolipin (aCL) test has been widely utilized by physicians since the mid-1980s for
diagnosing patients with the antiphospholipid syndrome (APS). Establishment of this …